Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · November 22, 2016

Low-Dose Aspirin Does Not Prevent Primary Cardiovascular Events in Patients With Type 2 Diabetes

Circulation

 

Additional Info

Disclosure statements are available on the authors' profiles:

Circulation
Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes: 10-Year Follow-Up of a Randomized Controlled Trial
Circulation 2016 Nov 15;[EPub Ahead of Print], Y Saito, S Okada, H Ogawa, H Soejima, M Sakuma, M Nakayama, N Doi, H Jinnouchi, M Waki, I Masuda, T Morimoto

Further Reading